Multiple signaling pathways are implicated in initiation and progression of bladder cancers, including mutations in PI3K/Akt and Ras/MAPK oncogenic path way components and alterations in the tumor suppressors, such as p53 and Rb. The gene discussed is AKT1; the disease is urinary bladder cancer.